Report Materials
Our objectives were to determine whether the State agency had (1) implemented the recommendations made in our previous audit of the Missouri drug rebate program and (2) established controls over collecting rebates on single source drugs administered by physicians. We found that the State agency had established controls over collecting rebates on single source drugs administered by physicians. However, the State agency had not covered all the weaknesses identified in our previous audit.
We recommended that the State agency (1) develop policies and procedures to reconcile the general ledger control account to the subsidiary ledgers/records and to the Form CMS-64.9R; (2) develop policies and procedures to identify the State agency's dispute resolution process, including policies and procedures to offer a State hearing mechanism to manufacturers in order to settle disputes; and (3) determine the actual accounts receivable balance as of June 30, 2006, and amend the Form CMS-64.9R to include all outstanding rebate balances. The State agency generally agreed with our findings and recommendations.
Notice
This report may be subject to section 5274 of the National Defense Authorization Act Fiscal Year 2023, 117 Pub. L. 263.